Systematic Comparison of Dendritic Cell-based Immunotherapeutic Strategies for Malignant Gliomas: In Vitro Induction of Cytolytic and Natural Killer-like T Cells
- 1 November 2004
- journal article
- research article
- Published by Wolters Kluwer Health in Neurosurgery
- Vol. 55 (5) , 1194-1204
Abstract
To compare the efficacy of various immunotherapeutic strategies of loading dendritic cells (DCs) with whole-glioma cell antigens and characterize the effector responses induced. DCs were either fused with major histocompatibility complex (MHC)-matched glioma cells (Fusion) or pulsed with apoptotic tumor cells (DC/Apo), total tumor ribonucleic acid (RNA) (DC/RNA), or tumor lysate (DC/Lys). These tumor-DC preparations were then assessed for their phenotype, cytokine profile, and capacity to stimulate autologous peripheral blood mononuclear cells (PBMCs) in vitro. Phenotype and tumor-specific cytolytic activities of various effector cell populations were characterized and compared. The various tumor-DC preparations exhibited similar phenotype and cytokine profiles irrespective of the method of loading tumor-cell antigens. However, the fusion, DC/Apo, and DC/RNA induced superior tumor cytolytic activities in PBMCs compared with DC/Lys or DC and tumor controls. DC/Apo induced the greatest expansion of tumor-specific lymphocytes, as detected by trypan blue exclusion and thymidine incorporation assays. Flow cytometric analyses also revealed the highest relative percentages of T helper cells (CD3+CD4+), cytotoxic T lymphocytes (CTLs) (CD3+CD8+), and natural killer (NK)-like T cells (CD3+CD56+) in the DC/Apo group among all the groups studied, indicating that DC/Apo induced expansion of PBMCs bearing multiple T and NK cell markers. Interestingly, isolated NK-like T cells demonstrated significantly higher tumor cytotoxicity compared with CTLs isolated from the same groups and was also non-MHC-restricted. Apoptotic tumor cells may be an optimal source of whole-tumor-cell antigen for immunotherapy of gliomas. The study also demonstrates for the first time that both CTLs and NK-like T cells are expanded and stimulated by mature, tumor-pulsed DCs.Keywords
This publication has 26 references indexed in Scilit:
- Relative survival rates and patterns of diagnosis analyzed by time period for individuals with primary malignant brain tumor, 1973–1997Journal of Neurosurgery, 2003
- Clinical implications of antigen transfer mechanisms from malignant to dendritic cellsExperimental Hematology, 2002
- Heat shock protein 70: role in antigen presentation and immune stimulationInternational Journal of Hyperthermia, 2002
- Dendritic cell vaccines for cancer therapyCancer Treatment Reviews, 2001
- T-cell-directed cancer vaccines: mechanisms of immune escape and immune toleranceExpert Opinion on Biological Therapy, 2001
- Resistance of Pancreatic Carcinoma Cells Is Reversed by Coculturing NK-like T Cells with Dendritic Cells Pulsed with Tumor-Derived RNA and CA 19-9Molecular Therapy, 2001
- MODULATION OF CELL SURFACE MARKERS ON NK-LIKE T LYMPHOCYTES BY USING IL-2, IL-7 OR IL-12 IN VITRO STIMULATIONCytokine, 2000
- HLA class I expression on human cancer cellsHuman Immunology, 2000
- The heat shock protein gp96 induces maturation of dendritic cells and down-regulation of its receptorEuropean Journal of Immunology, 2000
- Treatment of intracranial gliomas with bone marrow—derived dendritic cells pulsed with tumor antigensJournal of Neurosurgery, 1999